Download Medical Notes on Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020

Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020 Medical Notes

About This Presentation

Description:The coronavirus pandemic has been the driving force shaping the biopharma and medtech sectors over the first half of 2020. And, while much of the fallout has been predictable, certain events and trends have surprised. Check out the Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020 for more details

Tags:Pharma, Biotech, Medtech Half-Year Review, 2020 , coronavirus, pandemic

Published on: Jul 30, 2020 | Views : 1554 | Downloads : 0

Comment

Transcript

No transcript available for this presentation

User Presentation
Related Presentations

2020 US and global life sciences outlook

By: MattB
Views: 1213

Value of Personalized Medicine

By: MattB
Views: 1424

Rare Diseases and the Orphan Drug Act in the US

By: MattB
Views: 1975

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2020 - Booklet 5

By: MattB
Views: 1436

Taming big Pharma

By: MattB
Views: 1137

Evaluate Vantage Pharma, Biotech & Medtech 2019 in Review

By: MattB
Views: 1229

Electrolyte Disorders

By: huyen
Views: 769

The financialisation of Big Pharma

By: MattB
Views: 1089

Evaluate Vantage Pharma, Biotech & Medtech Half-Year Review 2019

By: MattB
Views: 1058

Understanding Neuromuscular Disease Care Current State and Future Prospects

By: docshare
Views: 1184

MattB

About : An experienced pharma professional managing sales, marketing and brand management of top global pharma products Presently leading a team of experts in the development and execution of pharma eCommerce strategies that support GSK products to HCP customers.
Occupation : Medical Professional
Specialty : Other Health Professionals
Country : United States of America
Website :

HEALTH A TO Z